Menu
GeneBe

rs4658

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_006516.4(SLC2A1):c.*462G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.262 in 595,632 control chromosomes in the GnomAD database, including 24,313 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.34 ( 10919 hom., cov: 32)
Exomes 𝑓: 0.23 ( 13394 hom. )

Consequence

SLC2A1
NM_006516.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: -0.308
Variant links:
Genes affected
SLC2A1 (HGNC:11005): (solute carrier family 2 member 1) This gene encodes a major glucose transporter in the mammalian blood-brain barrier. The encoded protein is found primarily in the cell membrane and on the cell surface, where it can also function as a receptor for human T-cell leukemia virus (HTLV) I and II. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia. [provided by RefSeq, Apr 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 1-42926579-C-G is Benign according to our data. Variant chr1-42926579-C-G is described in ClinVar as [Benign]. Clinvar id is 297374.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.585 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SLC2A1NM_006516.4 linkuse as main transcriptc.*462G>C 3_prime_UTR_variant 10/10 ENST00000426263.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SLC2A1ENST00000426263.10 linkuse as main transcriptc.*462G>C 3_prime_UTR_variant 10/101 NM_006516.4 P1

Frequencies

GnomAD3 genomes
AF:
0.341
AC:
51840
AN:
151984
Hom.:
10880
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.590
Gnomad AMI
AF:
0.104
Gnomad AMR
AF:
0.364
Gnomad ASJ
AF:
0.201
Gnomad EAS
AF:
0.313
Gnomad SAS
AF:
0.266
Gnomad FIN
AF:
0.246
Gnomad MID
AF:
0.266
Gnomad NFE
AF:
0.218
Gnomad OTH
AF:
0.308
GnomAD4 exome
AF:
0.235
AC:
104080
AN:
443528
Hom.:
13394
Cov.:
7
AF XY:
0.235
AC XY:
53402
AN XY:
227240
show subpopulations
Gnomad4 AFR exome
AF:
0.598
Gnomad4 AMR exome
AF:
0.370
Gnomad4 ASJ exome
AF:
0.191
Gnomad4 EAS exome
AF:
0.319
Gnomad4 SAS exome
AF:
0.257
Gnomad4 FIN exome
AF:
0.236
Gnomad4 NFE exome
AF:
0.212
Gnomad4 OTH exome
AF:
0.243
GnomAD4 genome
AF:
0.342
AC:
51949
AN:
152104
Hom.:
10919
Cov.:
32
AF XY:
0.342
AC XY:
25458
AN XY:
74340
show subpopulations
Gnomad4 AFR
AF:
0.591
Gnomad4 AMR
AF:
0.364
Gnomad4 ASJ
AF:
0.201
Gnomad4 EAS
AF:
0.313
Gnomad4 SAS
AF:
0.266
Gnomad4 FIN
AF:
0.246
Gnomad4 NFE
AF:
0.218
Gnomad4 OTH
AF:
0.307
Alfa
AF:
0.137
Hom.:
237
Bravo
AF:
0.359
Asia WGS
AF:
0.321
AC:
1117
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Dystonia 9 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Encephalopathy due to GLUT1 deficiency Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
Cadd
Benign
2.5
Dann
Benign
0.38

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4658; hg19: chr1-43392250; API